Otitis media with effusion and grommet decisions — branching viva

Opening question

Examiner: Take me through this child. What is the diagnosis, and what is your frame for managing it? [3]

Candidate: The diagnosis is persistent bilateral otitis media with effusion — glue ear. The well, afebrile child with dull, retracted, amber tympanic membranes and fluid levels, presenting with hearing difficulty and falling behind at preschool rather than with pain or fever, is the classic picture, and the four-month duration places her beyond the three-month threshold. My frame is to confirm the effusion with tympanometry and document the hearing with audiometry, then apply the grommet criterion: bilateral OME for three months or longer with documented hearing difficulty warrants referral for bilateral tympanostomy tubes. [2] [3]

Examiner: How do you distinguish glue ear from acute otitis media? [2]

Candidate: The distinction is clinical and turns on the acute infective signs. Glue ear is non-purulent fluid behind an intact, dull, retracted drum, with no pain, no fever and a well child; it presents with hearing difficulty. Acute otitis media has acute ear pain, fever and a systemically unwell child, and a bulging, opaque, red or yellow drum with loss of landmarks. Glue ear often follows an acute infection as residual fluid, which is the bridge between the two. [2] [3]

Branch 1 — pathophysiology and the tympanogram

Examiner: Why do young children get glue ear so often? [5]

Candidate: Because of the immature Eustachian tube. Compared with an adult's, a young child's tube is shorter, more horizontal and more compliant, so it ventilates the middle ear poorly and allows nasopharyngeal contents to reflux in more easily. Add frequent viral upper-respiratory infections that swell the lining, and the tube dysfunction is intermittent or persistent through the preschool years. When the tube fails, the middle-ear lining absorbs the trapped gases, pressure falls below atmospheric, the drum retracts, and the pressure gradient drives a transudation of fluid that cannot clear. As the tube lengthens and stiffens with growth, OME becomes uncommon. [5]

Examiner: How does tympanometry help you, and how do you read it? [2]

Candidate: Tympanometry measures eardrum compliance across a range of pressures and classifies the middle ear. A type A trace has a normal peak at around zero decapascals and means a normally ventilated middle ear. A type B trace is flat, with no peak, and indicates a middle-ear effusion — this is the confirmation I am looking for in OME. A type C trace has its peak shifted into the negative-pressure range and indicates Eustachian tube dysfunction without a frank effusion. For this child I would expect type B traces bilaterally. [2] [3]

Branch 2 — the grommet decision and the evidence

Examiner: What is your grommet criterion, and does this child meet it? [3]

Candidate: The AAO-HNS 2022 guideline recommends offering bilateral tympanostomy tube insertion to children with bilateral OME persisting three months or longer and documented hearing difficulties, and is explicit that tubes should not be inserted for a single episode under three months. This child meets all criteria: bilateral OME for four months, a documented conductive hearing loss, and clear educational impact. I would therefore refer her to ENT for bilateral grommets, with the tympanometry and audiometry documented. [3]

Examiner: What will you tell the family about the long-term benefit? [1]

Candidate: I would be honest that grommets restore hearing to normal while the tubes are patent, typically six to eighteen months, but that the hearing advantage over no-treatment narrows by around twelve months as the non-operated ear also resolves. More importantly, the Paradise randomised trials, following children to age nine to eleven years, found no difference in developmental, language, academic or behavioural outcomes between early and delayed insertion. So I would frame the operation as treating her current hearing and educational impact, not as preventing future developmental harm. [1] [2]

Branch 3 — what does not work, and the at-risk child

Examiner: What about antibiotics or steroids? [7]

Candidate: Neither has a lasting role. The Cochrane review of antibiotics for OME found they may produce short-term resolution but the effect is small, does not persist, and the harms of resistance and side effects outweigh any benefit, so they are not recommended for routine OME. Oral and topical steroids similarly lack a durable effect. During the watchful-waiting period I can offer autoinflation with a nasal balloon device, which has modest benefit in a child old enough to use it. [7]

Examiner: When would you lower the threshold and refer earlier than three months? [3]

Candidate: For the at-risk child, in whom even a mild additive conductive loss has a higher developmental cost. That includes children with Down syndrome, cleft palate, a permanent sensorineural hearing loss, developmental delay, autistic spectrum disorder, or blindness. I would also refer early and use a lower threshold to treat in an Aboriginal or Torres Strait Islander child with persistent disease, given the high burden of early, severe otitis media and its long-term educational cost in that population. [3]

Wrap

Examiner: Summarise the glue-ear stance in one sentence. [3]

Candidate: Otitis media with effusion is fluid behind an intact drum without acute infective signs, most of it resolves within three months, so the default is watchful waiting — but a child with bilateral OME for three months or longer and documented hearing difficulty is referred for bilateral grommets, reserving a deliberately lower threshold for the at-risk and Indigenous child, and remembering that in otherwise normal children the operation treats current hearing and developmental impact rather than preventing long-term harm. [1] [3]